GI Supply secures FDA clearance for new submucosal lifting agent

GI Supply’s new submucosal lifting agent is intended for the lift of polyps, adenomas, early-stage cancers, and other gastrointestinal lesions before excising with a snare or other suitable endoscopic devices. Credit: Numstocker / Shutterstock.